Our Services
Medical Information
Helpful Resources
Published on: 10/22/2026
Antacids such as calcium carbonate neutralize acid on contact and can ease heartburn in about 5 minutes, though relief usually fades within 30 to 60 minutes. Famotidine, an H2 blocker, starts working in roughly 15 to 60 minutes and can suppress acid for up to 10 to 12 hours, while omeprazole, a proton pump inhibitor, often takes 1 to 4 days to reach full effect but delivers the strongest, longest lasting control for frequent or daily symptoms. Which option fits best depends on how fast you need relief, how often symptoms occur, when you take the dose, and other medications you use, so see below for the important details before choosing.
If burning, regurgitation, or chest discomfort keeps returning despite over the counter treatment, the real issue may be acid reflux, gastritis, an ulcer, or something unrelated to acid entirely, and each needs a different approach. Take a free, instant online symptom check to see what your symptoms could mean and get clear guidance on your next steps.
Last reviewed for medical accuracy: 10/22/2026
When you experience heartburn, acid reflux or indigestion, you have three main over-the-counter options to calm your stomach acid: antacids, famotidine (an H2 blocker) and omeprazole (a proton pump inhibitor, or PPI). Each works differently, with distinct speed, duration and safety profiles. Below, we compare them side by side to help you decide which may fit your needs best.
Antacids
Famotidine (H2 Blocker)
Omeprazole (PPI)
| Medication | Onset | Peak Effect | Duration |
|---|---|---|---|
| Antacid | 5–10 minutes | 20–30 minutes | 30–60 minutes |
| Famotidine | 30–60 minutes | 1–3 hours | 10–12 hours |
| Omeprazole | 1–4 hours | 2–4 hours after | 24–48 hours (up to 72 in some people) |
Clinical guidelines often recommend starting with antacids or H2 blockers for occasional heartburn. If symptoms persist or occur more than twice a week, shifting to a PPI like omeprazole is usually advised.
Note: Side effects are rare at typical over-the-counter doses and durations (two to four weeks). Always follow label instructions or your doctor’s advice.
When deciding among antacid vs famotidine vs omeprazole, consider:
Speed of relief needed
Frequency of symptoms
Severity of condition
Duration of use
While most heartburn is harmless, persistent or severe symptoms can signal a more serious problem. Talk to your doctor if you experience:
If you have any life-threatening or alarming signs, seek immediate medical care.
Not sure which option suits you or if your symptoms are serious? Try a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you understand possible causes and next steps before you see a medical professional.
Remember, individual responses vary. Use this guide to inform your choice of antacid vs famotidine vs omeprazole, and always consult a healthcare professional for personalized advice. If you ever feel your symptoms could be serious, please speak to a doctor right away.
(References)
* Holtermüller KH, Bohlen E, Castro M, Weis HJ. [Considerations on antacid therapy]. Med Klin. 1977 Jul 29;72(30):1229-41. PMID: 329089.
* Heiselman DE, Chapman J, Malik M, Riegnor E. Hemodynamic status during famotidine infusion. DICP. 1990 Dec;24(12):1163-5. doi: 10.1177/106002809002401202. PMID: 2089822.
* Hollander D, Harlan J. Antacids vs placebos in peptic ulcer therapy. A controlled double-blind investigation. JAMA. 1973 Dec 3;226(10):1181-5. PMID: 4584411.
* Fisher JR. Evaluating antacids. N Z Med J. 1969 May;69(444):320-1. PMID: 5256213.
* Misiewicz JJ. Medical management of peptic ulcer. Postgrad Med J. 1984 Nov;60(709):751-9. doi: 10.1136/pgmj.60.709.751. PMID: 6095240; PMCID: PMC2418060.
* Kendall MJ, Spannuth F, Walt RP, Gibson GJ, Hale KA, Braithwaite R, Langman MJ. Lack of effect of H2-receptor antagonists on the pharmacokinetics of alcohol consumed after food at lunchtime. Br J Clin Pharmacol. 1994 Apr;37(4):371-4. doi: 10.1111/j.1365-2125.1994.tb04291.x. PMID: 8018458; PMCID: PMC1364738.
* Horie S, Hasebe K, Koshikawa H, Tsuchiya S, Yano S, Watanabe K. Stimulatory effect of dibutyryl cyclic GMP on acid secretion in mouse isolated stomach and on histamine release in gastric mucosal cells. J Physiol Paris. 2000 Jan-Feb;94(1):25-9. doi: 10.1016/s0928-4257(99)00107-2. PMID: 10761685.
* Hasebe K, Horie S, Komasaka M, Yano S, Watanabe K. Stimulatory effects of nitric oxide donors on gastric acid secretion in isolated mouse stomach. Eur J Pharmacol. 2001 May 25;420(2-3):159-64. doi: 10.1016/s0014-2999(01)00995-5. PMID: 11408038.
* Mutoh H, Sugano K. [Duodenal ulcer]. Nihon Rinsho. 2002 Jan;60 Suppl 1:151-60. PMID: 11838107.
* Yeramaneni S, Doshi P, Sands K, Cooper M, Kurbegov D, Fromell G. Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized Patients With Coronavirus Disease 2019 From a Large Healthcare System. Gastroenterology. 2021 Feb;160(3):919-921.e3. doi: 10.1053/j.gastro.2020.10.011. Epub 2020 Oct 12. PMID: 33058865; PMCID: PMC7550093.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.